Global Intraosseous Infusion Device Market was valued at US$ 3.5 Bn in 2020 & is expected to reach US$ 7.9 Bn at a CAGR of 7.6% during the forecast per
According to a recent study by Future Market Insights (FMI), the global intraosseous (IO) infusion devices is expected to witness high growth during the forecast period. The market is expected to grow from US$ 3.5 Bn in 2020 to over US$ 7.9 Bn by 2031. It will therefore register CAGR of around 7.6% over the forecast.
According to a recent study by Future Market Insights (FMI), the global intraosseous (IO) infusion devices is expected to witness high growth during the forecast period. The market is expected to grow from US$ 3.5 Bn in 2020 to over US$ 7.9 Bn by 2031. It will therefore register CAGR of around 7.6% over the forecast.
According to a recent study by Future Market Insights (FMI), the global intraosseous (IO) infusion devices is expected to witness high growth during the forecast period. The market is expected to grow from US$ 3.5 Bn in 2020 to over US$ 7.9 Bn by 2031. It will therefore register CAGR of around 7.6% over the forecast.
Key Takeaways from Intraosseous Infusion Devices Market StudyBy product, EZ-IO holds the maximum share of 21.4% in the market in 2021, expanding at 7.6% CAGR during the forecast period.By route of administration, the sternum segment will account for 30.8% of the market share in 2021, indicating the highest demand.By.